Brief: Elanco Animal Health Q3 Revenue USD 1,030 Million Vs. IBES Estimate USD 1,034 Million
07/11/2024 11:27
Nov 07 (Reuters) - Elanco Animal Health Q3 adjusted EBITDA USD 163 million vs. IBES estimate USD 160.6 million. * Q3 adjusted net income USD 66 million vs. IBES estimate USD 59.1 million * Q3 adjusted EPS USD 0.13 vs. IBES estimate USD 0.12 * outlook FY adjusted EPS USD 0.89-0.95 * outlook FY EPS USD 0.58-0.64 * outlook FY revenue USD 4,420-4,450 million * outlook FY adjusted EBITDA USD 900-930 million * outlook FY net income USD 286-317 million
Recent news on Elanco Animal Health Incorporated
See all newsBrief: Elanco Animal Health Appoints Jamie Preston As Chief People Officer
U.S. STOCKS ON THE MOVE-Walt Disney, Alphabet, Kraft Heinz
U.S. STOCKS ON THE MOVE-Wynn Resorts, Griffon, Kratos Defense, Amgen
Elanco Animal Health Incorporated reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Cencora, Charles River, Twist Bioscience